PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

LinkedIn

Anterior lumbosacral plexus block outperforms lumbar epidural for lower limb surgery

ropivacainebupivacainelocal anestheticslumbosacral plexus blocklumbar epiduralpatient-controlled epidural analgesiapostoperative analgesiaorthopedic surgeryregional anesthesiarandomized controlled trial Medication Safety

Background Information

New block technique outperforms epidurals in lower limb surgery.

Effective pain management in lower limb surgery can improve recovery and patient satisfaction. The novel anterior approach was superior, showing lower pain scores and less rescue medication use compared to epidural (P < 0.001). This method provides effective analgesia with fewer side effects like hypotension and postoperative nausea and vomiting (PONV). Single puncture, dual injection offers better pain control and safety than traditional epidurals for lower limb surgeries.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: Kaur S, Mohammed S, Chhabra S, Kumar R, Paliwal B, Gahlot N, Bhatia P

Citation: Kaur S, Mohammed S, Chhabra S, et al. Analgesic efficacy of an ultrasound-guided single puncture, dual injection, anterior approach targeting branches of the lumbosacral plexus versus lumbar epidural for unilateral lower limb orthopedic surgery: A randomized controlled study. Journal of anaesthesiology, clinical pharmacology. 2026;42(3):392-399. doi:10.4103/joacp.joacp_394_25

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →